APA BIPOLAR DISORDER GUIDELINE LISTS LITHIUM AS FIRST CHOICE
• By The Pink Sheet
APA BIPOLAR DISORDER GUIDELINE LISTS LITHIUM AS FIRST CHOICE line of therapy, but notes that the newer drugs valproic acid and carbamazapine are also good first choices of treatment, depending on the patient. The American Psychiatric Association, which released its first guideline "for the treatment of patients who have had at least one episode of mania (i.e. Bipolar I Disorder)," said at a Dec. 7 press conference that the guidelines are designed to help psychiatrists diagnose and treat the disease, also known as manic-depressive illness. Bipolar Disorder occurs in approximately 3 mil. American adults, or 1.6% of the U.S. population, according to a recent National Depressive & Manic Depressive Association survey.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Advanz Pharma would have had to show that the European Commission’s decision to revoke Ocaliva’s conditional marketing approval risked causing serious and irreparable harm, according to lawyers from Van Bael & Bellis.
We are conducting a survey to better understand our subscribers’ content and delivery needs. If there are any changes you’d like to see in coverage topics, article format, or the method in which you access the Pink Sheet – or if you love it how it is – now is the time to have your voice heard.
Aspen Neurosciences and BlueRock Therapeutics see hope for artificial intelligence to improve the quality of cell therapies to replace dopaminergic neurons in Parkinson's disease.
While Japan tries to balance its healthcare costs, the major US industry group is concerned reimbursement pricing practices in the country could influence US levels under Trump's MFN policy.